Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120

Journal of Virology(2025)10.1128/jvi.02267-24Source: DataRank Database

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120 is a research paper published in Journal of Virology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 2.95)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Ling Niu ORCID,Halima Medjahed,Shilei Ding ORCID,Mehdi Benlarbi ORCID,Étienne Bélanger

Live enrichment

PubMed:40145736 PMC:PMC11998491 OpenAlex:https://openalex.org/W4408907619

Canadian Government | Canadian Institutes of Health Research

Grant: team grant

Canada Foundation for Innovation

Grant: 41027

HHS | National Institutes of Health

Grant: R01

NIAID NIH HHS

Grant: P01 AI162242

NIAID NIH HHS

Grant: R01 AI186809

NIAID NIH HHS

Grant: UM1 AI164562

NIAID NIH HHS

Grant: R01 AI148379

NIAID NIH HHS

Grant: R01 AI174908

NIAID NIH HHS

Grant: R01 AI176531

NIAID NIH HHS

Grant: R01 AI150322

FWCI

2.95

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/jvi.02267-24

publisherhttps://doi.org/10.1128/jvi.02267-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.02267-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40145736

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11998491

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentCytomegalovirus and herpesvirus researchHIV Envelope Protein gp120HIV-1HIV Envelope Protein gp41HumansDrug Resistance, ViralAnti-HIV AgentsHIV InfectionsCD4 Antigens

MeSH Terms

HumansHIV-1HIV InfectionsHIV Envelope Protein gp120HIV Envelope Protein gp41CD4 AntigensAnti-HIV AgentsDrug Resistance, Viral

Keywords

Residue (chemistry)Gp41GlycoproteinBiologyBiochemistryHistidineAmino acidGeneticsEpitopeAntibodyHIVgp120envCrf01_aeTemsavirCd4mc

Sustainable Development Goals

SDG 0: Good health and well-being

A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120

FAIR Checklist

Authors (12)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)